SynInnova is a reputed Canadian contract research organization (CRO). After operating for over 10 years from the facility of the University of Alberta campus, we have finally decided to build our own research facility in the City of Edmonton, Canada to better serve the scientific community. Over the years, SynInnova has been reliable and valuable partner and has been supplying many "hard-to-make" custom research chemicals in a timely manner and at competitive prices to support life science research in various therapeutic areas. Even more exciting news is SynInnova has taken a bold step in setting up a state-of-the-art research facility in the chemical hub of Hyderabad, India. Operations are starting from August 01, 2023, employing over 40 research chemists with easy access to analytical facilities, chiral synthesis, and separation. Along with our existing core business model that is making and supplying intermediates and/or final products as life science research chemicals, SynInnova is now getting ready to take challenges not only in custom research chemicals in gram quantities, but also in ever demanding library synthesis of drug-like molecules, scale up of key intermediates and process research chemistry.
We support scientific research worldwide by preparing and supplying robust and unique research chemicals to fulfill your research needs. Furthermore, we support your life science research in major therapeutic areas like oncology, virology, anti-infective, diabetes, autoimmune diseases, inflammation and pain, alzheimer and so on by supplying early, mid-stage and advanced key chemical intermediates. The biological targets are of diverse in nature like inhibitors, agonists, antagonists, modulators and blockers. We could synthesize FDA approved drugs and drugs under clinical trials as reference compounds and stable labelled isotopic compounds. We could also assist you in making large number of analogs based on your proprietary designed scaffold in a specific therapeutic area. We also offer both compound based custom synthesis projects and FTE based medicinal chemistry services at a competitive rate with strict confidentiality and exceptional quality.
Our in-depth knowledge in life science research will support your research program by synthesizing and supplying robust key building blocks for a specific biological target in major therapeutic areas. Furthermore, we have the ability to assist your in-house research effort by providing medicinal chemistry support, if required, which is an added benefit to expedite your research program and to achieve your goal in a short time frame.
Since 2008 we have collaborated and delivered a number of commercially inaccessible research chemicals to the multinational companies like Pfizer, Merck, Gilead, Sanofi-Aventis, Bayer, Novartis, abbivie, Sigma-Aldrich, Alfa-Aesar (Thermo-Fisher) and worked with over 500 research labs worldwide. Institutes like NIH, NRC, Broad Institute, Kings College London, Stanford University and UCLA are to name a few. Robust building blocks, drug impurities, chiral intermediates, drug metabolites and labelled compounds - whatever is required SynInnova is willing to take challenges. Completing projects on time at competitive price and scalable to gram quantity is our strength.
To receive the information that is relevant to your work, subscribe to our Newsletter.
Note : To subscribe, please use the email address from your company or academic institution. Non-institutional and personal email addresses are not accepted.